BE1003340A3 - Nouvelle utilisation therapeutique des alpha-aminofluorocetones. - Google Patents

Nouvelle utilisation therapeutique des alpha-aminofluorocetones. Download PDF

Info

Publication number
BE1003340A3
BE1003340A3 BE9000075A BE9000075A BE1003340A3 BE 1003340 A3 BE1003340 A3 BE 1003340A3 BE 9000075 A BE9000075 A BE 9000075A BE 9000075 A BE9000075 A BE 9000075A BE 1003340 A3 BE1003340 A3 BE 1003340A3
Authority
BE
Belgium
Prior art keywords
alpha
aminofluorocetones
therapeutic use
new therapeutic
phenylalanylalanylfluoromethylketone
Prior art date
Application number
BE9000075A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1003340A3 publication Critical patent/BE1003340A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

La présente invention a pour objet l'utilisation d'alpha-aminofluorocétones, spécialement la benzyloxycarbonyl-1-phénylalanylalanylfluorométhylcétone, pour la préparation de médicaments ayant une activité cardiovasculaire et anti-hypertensive.
BE9000075A 1989-01-26 1990-01-22 Nouvelle utilisation therapeutique des alpha-aminofluorocetones. BE1003340A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH23889 1989-01-26

Publications (1)

Publication Number Publication Date
BE1003340A3 true BE1003340A3 (fr) 1992-03-03

Family

ID=4182438

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9000075A BE1003340A3 (fr) 1989-01-26 1990-01-22 Nouvelle utilisation therapeutique des alpha-aminofluorocetones.

Country Status (6)

Country Link
JP (1) JPH02247123A (fr)
BE (1) BE1003340A3 (fr)
DE (1) DE4001087A1 (fr)
FR (1) FR2641972A1 (fr)
GB (1) GB2227411A (fr)
IT (1) IT1239745B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5101068A (en) * 1990-02-16 1992-03-31 Prototek Inc. Magnesium fluoromalonates
JP3228347B2 (ja) * 1991-06-25 2001-11-12 三菱化学株式会社 シクロプロペノン誘導体
US5395958A (en) * 1992-09-30 1995-03-07 Mitsubishi Kasei Corporation Cyclopropene derivatives
ATE197591T1 (de) * 1995-03-31 2000-12-15 Naeja Pharmaceutical Inc 4-substituierte-3-peptidyl-azetidin-2-on-deriva e als cystein-proteinase inhibitoren

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 108, no. 17, 25 avril 1988, page 798, abr�g� no. 150981h, Columbus, Ohio, US; & ZA-A-86 06 642 (MERCK & CO., INC.) 29-04-1987 *
CHEMICAL ABSTRACTS, vol. 86, no. 11, 14 mars 1977, page 186, abr�g� no. 67205q, Columbus, Ohio, US; V.N. OREKHOVICH et al.: "Enzymological factors in vascular tension regulation", & VESTN. AKAD. MED. NAUK. SSSR 1976, (9), 42-7 *

Also Published As

Publication number Publication date
IT1239745B (it) 1993-11-15
JPH02247123A (ja) 1990-10-02
DE4001087A1 (de) 1990-08-02
IT9047551A0 (it) 1990-01-22
GB9001453D0 (en) 1990-03-21
GB2227411A (en) 1990-08-01
FR2641972A1 (fr) 1990-07-27
IT9047551A1 (it) 1990-07-27

Similar Documents

Publication Publication Date Title
FR2621245B1 (fr) Table d'operation orthopedique pour membres et notamment pour membres inferieurs
EP0599819A3 (en) Additives enhancing topical actions of therapeutic agents.
OA09123A (fr) Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.
DE3772113D1 (de) Dosierungsform des nitrofurantoins.
SG49228A1 (en) Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity
FR2694296B1 (fr) Peptides inhibant l'activité des protéines ras, préparation et utilisation.
BE1003340A3 (fr) Nouvelle utilisation therapeutique des alpha-aminofluorocetones.
IT1225474B (it) Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute.
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
IT8026233A0 (it) Derivato della n-acetil-cisteina ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT1222099B (it) Poliesteri del 4,4' diidrossibicicloesile
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
FR2620163B1 (fr) Blindage notamment pour coffre-fort et coffre-fort s'y rapportant
FR2580494B1 (fr) Composition cosmetique pour le traitement des cheveux, notamment des cheveux gras a base d'un extrait de millefeuille (achillea millefolium l)
SE8704240D0 (sv) Analgesic preparations
IT1228561B (it) Isomero otticamente attivo della cloperastina avente attivita' antitussiva, processo per la sua preparazione e composizioni farmaceutiche che lo contengono.
NL193317B (nl) 1,8-Diacyloxy-10-acylantronen en cosmetische en farmaceutische samenstellingen die ze bevatten.
IT8322045A0 (it) Per la loro preparazione e oligosaccaridi eterogenei relative composizioni complessabili ed alfa -idosani ad farmaceutiche. attivita' terapeutica, procedimento
FR2706303B1 (fr) Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
IT9021063A0 (it) Sintesi di attivita' anti-hiv, 3h-tiazolo 3,4-a benzimidazoli 1-sostituiti
IT1134457B (it) Derivato dell'alfa-mercapto propionilglicina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
FR2530360B1 (fr) Regle pour la prescription de medicaments, notamment d'aminosides
FR2652747B1 (fr) Application d'agents actifs pour la preparation d'un medicament destine au traitement de maladies auto-immunes.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19920131